INVESTIGATION OF A ROLE OF THE IMMUNOGENICITY OF INFLIXIMAB IN THE THERAPY OF ANKYLOSING SPONDYLITIS
At present, there are a number of unsolved problems associated with unawareness of the causes and ways to prevent the inefficacy of tumor necrosis factor-α inhibitors.Objective: to study the causes of secondary inefficacy of infliximab (INF), by analyzing its concentrations and antidrug antibody le...
Main Authors: | O. A. Rumyantseva, A. G. Bochkova, M. M. Urumova, M. V. Cherkasova, E. N. Aleksandrova, S. K. Solovyev, Sh. F. Erdes |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2016-09-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/2252 |
Similar Items
-
CLINICAL HETEROGENEITY OF EARLY AXIAL SPONDYLOARTHRITIS: ANALYSIS OF CLINICAL AND RADIOLOGICAL FINDINGS IN CRIMEA’S PATIENTS
by: A. V. Petrov, et al.
Published: (2015-04-01) -
Тяжелое течение анкилозирующего спондилита с резистентностью к медикаментозной терапии (клинические наблюдения)
Published: (2018-06-01) -
Experience with long-term infliximab therapy in patients with ankylosing spondylitis
by: Oksana Alekseevna Rumyantseva, et al.
Published: (2010-12-01) -
CLINICAL EXPERIENCE WITH ETANERCEPT IN THE TREATMENT OF PATIENTS WITH ANKYLOSING SPONDYLITIS
by: O. A. Rumyantseva, et al.
Published: (2018-05-01) -
ATTEMPT OF OVERCOMING SECONDARY INEFFECTIVENESS OF INFLIXIMAB IN A PATIENT WITH ANKYLOSING SPONDYLITIS USING PLASMAPHERESIS (A CASE REPORT)
by: Oksana Alekseyevna Rumyantseva, et al.
Published: (2014-02-01)